NASDAQ$LMRI

Lumexa Imaging Holdings, Inc · Q1 2026 earnings

Q1 2026 earnings ·

Briefing

Lumexa Imaging reported Q1 2026 net income of $1.7M on early commercial revenue.

For the quarter ended March 31, 2026, Lumexa Imaging reported net income of approximately $1.7 million versus a net loss of $7.7 million a year ago, as commercial imaging product revenue begins to scale from a small base.

  • Net income $1.7M vs prior-year loss.
  • Commercial imaging revenue ramping.
  • Margin improvement on scale.
  • Recent public company reporting.

Headline financials

Total Revenue

$253M

No prior period
EPS

$0.02

No prior period
Capital Expenditures

-$5.31M

No prior period
Free Cash Flow

-$2.38M

No prior period
Net Income

$1.72M

No prior period
Operating Income

$19.4M

No prior period
Cash & Equivalents

$51.2M

No prior period
Total Assets

$1.76B

No prior period

Revenue & EPS history

Lumexa Imaging Holdings, Inc · Revenue · Quarterly

$253M

Q1 2026
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Forward guidance

Growth tied to imaging product adoption and hospital accounts.

Tailwinds

  • Profitability inflection in Q1 2026.
  • YoY swing from loss to income.

Headwinds

  • Small revenue base; execution risk on launch.
  • Competitive diagnostic imaging market.

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro